About Chugai
Innovation
Sustainability
Stories
Investor Relations
News Room
Recruitment

Oct 15, 2012

FDA Approves Expanded Indication for ACTEMRA^®
in Rheumatoid Arthritis

Home
About Chugai
News
FDA Approves Expanded Indication for ACTEMRA® in Rheumatoid Arthritis

You are now moving to an external website.

Access the link(Open in a new window)